Oppenheimer Downgrades Crescent Capital BDC to Perform, Lowers Price Target to $16
Benzinga Newsdesk 5 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Oppenheimer analyst Mitchel Penn downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Perform and lowers the price target from $19 to $16.
Oppenheimer analyst Mitchel Penn downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Perform and lowers the price target from $19 to $16.